Abstract:An experimental study was conducted to evaluate the pharmacological activity of plumbagin against Folic acid-induced acute kidney injury/renal fibrosis. A total of 30 male
Swiss albino mice were procured and acclimatized for one week before experimentation. Mice were randomly assigned to five groups of 6 animals each. Group 1 (control group) was administered normal saline. Group 2 was given Folic acid @ 250mg/kg BW IP given on 1
st day of the experiment, Group 3 was kept as plumbagin
per se group (10mg/kg IP). Groups 4 and 5 were kept as treatment groups with plumbagin @ 5 mg/kg BW IP and 10mg/kg IP, respectively, daily, along with folic acid on 1
st day of the experiment. The experiment was conducted for a period of 14 days. On the 15
th day the mice were sacrificed and kidneys were collected for the analysis of anti-oxidant parameters.
The present study revealed a significant alteration in anti-oxidant profile (Nitrite assay, TBARS, SOD, GSH and Catalase) of mice treated with folic acid (group 2) when compared to sham (group 1) and there was a significant amelioration of alterations in all the parameters in group 4 and 5 when compared to Folic acid control group 2. The values of group 1 and 3 were comparable without any significant differences.
In conclusion, plumbagin was found to possess the ameliorating action against folic acid-induced oxidative stress. The results revealed a greater significance of amelioration in group 5 compared to group 4, as seen through restoration of anti-oxidant enzyme levels Hence, plumbagin can be used as a protective strategy for renal injury.